2019-11-13T09:44:06-06:00 2018-12-31 521855942 TATE AND TRYON 2021 L STREET NW SUITE 400 WASHINGTON DC 20036 990 2018-01-01 231682043 AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS AMER 7038366981 528 NORTH WASHINGTON STREET ALEXANDRIA VA 22314 SHARON SWAN CHIEF EXECUTIVE OFFICER 7038366981 2019-11-13 1 SARA SMITH P01332734 2022932200 216.59.105.130 2019-11-13 09:44:02 ES P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 5BC65B47B3A1F1CE2534BD8A8DAEFAC1BF945F16 2018 2020-03-31 21:24:44Z SHARON SWAN 528 NORTH WASHINGTON STREET ALEXANDRIA VA 22314 4666693 0 X WWW.ASCPT.ORG X 1900 DC ADVANCING CLINICAL PHARMACOLOGY, TRANSLATIONAL MEDICINE AND THERAPEUTICS FOR THE BENEFIT OF PATIENTS AND SOCIETY. 11 11 11 550 804 0 60695 168372 3285136 3491284 111004 114221 32514 24747 3489349 3798624 49340 35000 0 0 1404501 1505256 0 0 2488 2219372 2035237 3673213 3575493 -183864 223131 5142500 5194739 40213 54759 5102287 5139980 X ADVANCING CLINICAL PHARMACOLOGY, TRANSLATIONAL MEDICINE AND THERAPEUTICS FOR THE BENEFIT OF PATIENTS AND SOCIETY. 0 0 1689066 35000 1676868 ANNUAL MEETING: THE ASCPT ANNUAL MEETING IS AN INTERNATIONAL MEETING THAT ATTRACTS PARTICIPANTS FROM AROUND THE WORLD. A SPECTRUM OF TOPICS RELATING TO THE CONTINUUM OF DRUG DISCOVERY, DEVELOPMENT, REGULATION, AND UTILIZATION ARE DISCUSSED. THE MEETING OFFERS EDUCATIONAL SESSIONS AND POSTER PRESENTATIONS, LECTURES FROM TOP PROFESSIONALS IN THE INDUSTRY, AS WELL AS NETWORKING OPPORTUNITIES WITH CLINICAL PHARMACOLOGISTS FROM AROUND THE WORLD. THERE IS ALSO AN EXHIBIT HALL WITH REPRESENTATIVES FROM VARIOUS COMPANIES. 1071889 1132969 JOURNAL: CLINICAL PHARMACOLOGY AND THERAPEUTICS (CPT) IS THE AUTHORITATIVE CROSS-DISCIPLINARY JOURNAL IN EXPERIMENTAL AND CLINICAL MEDICINE DEVOTED TO PUBLISHING ADVANCES IN THE NATURE, ACTION, EFFICACY AND EVALUATION OF THERAPEUTICS. IT CONTINUES TO SEE IMPROVEMENTS IN THE NUMBER OF MANUSCRIPTS RECEIVED AND INCREASES IN SUBSCRIPTIONS. JOURNALS CLINICAL PHARMACOLOGY & THERAPEUTICS: PHARMACOMETRICS AND SYSTEMS PHARMACOLOGY (PSP) IS A TIMELY ONLINE-ONLY CROSS-DISCIPLINARY JOURNAL PUBLISHING ADVANCES IN QUANTITATIVE METHODS AS APPLIED IN PHARAMCOLOGY, PHYSIOLOGY AND THERAPEUTICS IN HUMANS. CLINICAL AND TRANSLATIONAL SCIENCE (CTS) HIGHLIGHTS ORIGINAL RESEARCH THAT HELPS BRIDGE LABORATORY DISCOVERIES WITH THE DIAGNOSIS AND TREATMENT OF HUMAN DISEASE. 537382 681447 MEMBER SERVICES: MEMBERSHIP IN ASCPT OFFERS A NUMBER OF BENEFITS WHICH DIRECTLY IMPACT ITS MEMBERS AND THEIR PROFESSIONAL DEVELOPMENT. IT PROVIDES A VARIETY OF INFORMATION TOOLS, SUCH AS THE CPT, PSP AND CTS JOURNALS, WEBINARS, WEBSITE AND EMAIL NEWSLETTER, EDUCATIONAL OPPORTUNITIES, SUCH AS THE ANNUAL MEETING, AND PROFESSIONAL DEVELOPMENT OPPORTUNITIES. 3298337 1 1 0 1 0 0 0 0 0 1 1 0 0 0 1 1 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 49 0 1 11 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 11 11 0 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 0 0 AL AK AZ AR CA CO CT DE FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY X THE SOCIETY 7038366981 528 NORTH WASHINGTON STREET ALEXANDRIA VA 22314 DAN HARTMAN MD PRESIDENT (AS OF 3/2018) 2.00 X X 0 0 0 KELLIE SCHOOLAR REYNOLDS PHARMD IMMED. PAST PRESIDENT (AS OF 3/2018) 2.00 X X 0 0 0 DAVID Y MITCHELL PHD PRESIDENT ELECT (AS OF 3/2018) 2.00 X 0 0 0 WALTER KRAFT MD FACP TREASURER 2.00 X X 0 0 0 BRIAN W CORRIGAN PHD DIRECTOR (AS OF 3/2018) 1.00 X 0 0 0 JILL FIEDLER-KELLY MS DIRECTOR 2.00 X 0 0 0 JEAN-MICHEL GRIES PHD PHARMD DIRECTOR (AS OF 3/2018) 1.00 X 0 0 0 VIRGINIA GINNY D SCHMITH PHD FCP DIRECTOR 2.00 X 0 0 0 AUBREY STOCH MD DIRECTOR 2.00 X 0 0 0 PAOLO VICINI PHD MBA DIRECTOR 2.00 X 0 0 0 LEI ZHANG PHD DIRECTOR (AS OF 3/2018) 1.00 X 0 0 0 JULIE A JOHNSON PHARMD IMMED. PAST PRESIDENT (TO 3/2018) 2.00 X X 0 0 0 ANNE C HEATHERINGTON PHD DIRECTOR (TO 3/2018) 2.00 X 0 0 0 SEAN HENNESSY PHARMD PHD DIRECTOR (TO 3/2018) 2.00 X 0 0 0 SHARON J SWAN FASAE CAE CEO 40.00 X 405850 0 64264 ELISE LAFFMAN-JOHNSON COO 40.00 X 177962 0 13156 LISA M INFELISE SENIOR DIRECTOR OF MEMBER SERVICES 40.00 X 115345 0 11795 EMMA SHUMEYKO MANAGING EDITOR 40.00 X 107572 0 11004 806729 0 100219 4 0 1 0 FREEMAN AUDIO VISUAL INC PO BOX 650519 DALLAS TX 752650519 AUDIO VISUAL SERVICES 289847 1 168372 168372 ANNUAL MEETING REGISTR 900099 1193892 1193892 JOURNALS 900099 1132969 1132165 804 MEMBERSHIP DUES 900099 681447 681447 EXHIBITS 900099 385191 385191 AM SPONSORSHIPS 900099 97785 97785 3491284 57290 57290 22695 22695 925000 868069 56931 56931 56931 MISCELLANEOUS 900099 2052 2052 2052 3798624 3490480 804 138968 X 29500 29500 5500 5500 662711 521254 141457 681262 579978 101284 39795 14242 25553 44828 44828 76660 68562 8098 24378 24378 90904 90904 16360 16360 397645 383472 11685 2488 192390 90935 101455 29741 29741 86885 49639 37246 850728 815528 35200 116761 116761 25167 25167 STRATEGIC PLAN 88965 10525 78440 MEMBERSHIP SERVICES 87367 87336 31 PRINTING 18762 18629 133 TAXES 6545 6545 2639 623237 -620598 3575493 3298337 274668 2488 201853 179120 670058 930344 400 1942233 515063 1485337 1427170 2278082 2173210 506770 484895 5142500 5194739 5101 40213 49658 40213 54759 X 4795380 4718773 306907 421207 5102287 5139980 5142500 5194739 223131 -185438 0 X X 1 X 0 0 0 X 46169 30259 99311 60695 168372 404806 3165820 2790322 3346031 3284012 3490480 16076665 3211989 2820581 3445342 3344707 3658852 16481471 0 1226890 916103 956864 1084223 1094756 5278836 1226890 916103 956864 1084223 1094756 5278836 11202635 102071 108018 92109 88903 79985 471086 102071 108018 92109 88903 79985 471086 3134 3134 12186 3547 6962 3081 2052 27828 3329380 2932146 3544413 3436691 3740889 16983519 0.65960 0.64890 0.02770 0.03010 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: INCOME FROM ACTIVITIES NOT NORMALLY RECURRING RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 3559133 3559133 327957 81989 0 0 311662 336034 332716 327957 1308369 1962554 77916 84009 83179 81989 327093 490640 482548 151296 -25867 51354 2568 554055 473937 18545 47693 54895 2732 482548 442881 38541 36173 40810 2848 473937 451852 3628 781 10059 3321 442881 471079 6043 26911 47961 4220 451852 0.23970 0.76030 0 0 186000 186000 1457619 327348 1130271 48239 45476 2763 250375 142239 108136 1427170 DUE TO INTERNATIONAL SOCIETY OF PHARMACOMETRICS 49658 49658 X PART V, LINE 4: PURPOSE OF ENDOWMENT: THE BOARD OF DIRECTORS HAS DESIGNATED CASH AND INVESTMENTS TO BE SET ASIDE TO MEET AT LEAST THREE MONTHS WORTH OF OPERATING EXPENSES. THE BOARD HAS ALSO DESIGNATED CERTAIN INVESTMENTS AND THE INCOME RELATED TO THOSE INVESTMENTS ACCOUNTS FOR PAYMENT OF THE SOCIETY'S AWARD PROGRAMS AT ITS ANNUAL MEETING. THE AWARDS PROGRAMS FOR WHICH INVESTMENTS HAVE BEEN SET ASIDE INCLUDE THE WILLIAM B. ABRAMS AWARD, THE RAWLS-PALMER AWARD, THE SHEINER-BEAL AWARD, THE GARY NEIL PRIZE, AND THE SCIENTIFIC AWARDS COMMITTEE. PART X, LINE 2: THE SOCIETY HAS EVALUATED ITS TAX POSITIONS FOR ALL OPEN TAX YEARS. CURRENTLY, THE TAX YEARS OPEN AND SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE ARE THE 2016, 2017, AND 2018 TAX YEARS. HOWEVER, THE SOCIETY IS NOT CURRENTLY UNDER AUDIT. BASED ON THE EVALUATION OF THE SOCIETY'S TAX POSITIONS, MANAGEMENT BELIEVES ALL TAX POSITIONS TAKEN WOULD BE UPHELD UNDER AN EXAMINATION. THEREFORE, NO PROVISIONS FOR THE EFFECTS OF UNCERTAIN TAX POSITIONS HAVE BEEN RECORDED FOR THE YEAR ENDED DECEMBER 31, 2018. 1 0 0 0 0 0 0 0 0 0 SHEINER-BEAL PHARMACOMETRICS AWARD ($1500 PER AWARD) EUROPE (INCLUDING ICELAND & GREENLAND) 1 1500 WIRE 2018 STUDENT TRAVEL GRANT ($500 PER AWARD) EAST ASIA AND THE PACIFIC 1 500 CHECK 2018 STUDENT TRAVEL GRANT ($500 PER AWARD) EUROPE (INCLUDING ICELAND & GREENLAND) 3 1500 CHECK 2018 STUDENT TRAVEL GRANT ($500 PER AWARD) NORTH AMERICA 2 1000 CHECK 2018 PRESIDENT TRAINEE AWARD ($500 PER AWARD) NORTH AMERICA 2 1000 CHECK 0 0 0 0 0 0 PART I, LINE 2: EACH YEAR ASCPT'S AWARDS PROGRAM PROVIDES AN ARRAY OF AWARDS THAT RECOGNIZE OUTSTANDING SCIENCE AND ACHIEVEMENT IN CLINICAL PHARMACOLOGY AND TRANSLATIONAL SCIENCE. ASCPT'S AWARDS SPAN THE CONTINUUM OF CLINICAL PHARMACOLOGY, TRANSLATIONAL MEDICINE, AND THERAPEUTICS. THE ARRAY OF AWARDS IS DESIGNED TO RECOGNIZE EVERY TURNING POINT IN THE CAREER PATH FROM YOUNG INVESTIGATOR TO SEASONED SCIENTIST WITH THE FOCUS ON EXCEPTIONAL ACHIEVEMENTS IN THE DIMENSIONS THAT THE AWARDS ARE FOCUSED. EACH AWARD CANDIDATE IS NOMINATED THROUGH THE SUBMISSION OF A NOMINATION PACKET THAT INCLUDES A SUMMARIZED CV AND COMPREHENSIVE ASSESSMENT OF ALL ASPECTS OF THE CANDIDATES OUTSTANDING ATTRIBUTES. ADDITIONALLY, 1 TO 3 RECOMMENDATIONS MUST BE INCLUDED FROM INDIVIDUALS AS WELL AS THE CANDIDATES COMPLETE CV AND HIGHLIGHTS OF NOTEWORTHY SCIENTIFIC ACCOMPLISHMENTS. AFTER THE SELECTION PROCESS IS COMPLETE, THE RECIPIENTS RECEIVE THE MONETARY AWARD, A TRAVEL STIPEND TO THE ANNUAL MEETING AND RECOGNITION DURING THE ANNUAL MEETING. 1 2018 PRESIDENT TRAINEE AWARD ($500 PER AWARD) 13 6500 2018 STUDENT TRAVEL GRANT ($500 PER AWARD) 21 10500 ASCPT-FDA WILLIAM B. ABRAMS AWARD ($500 PER AWARD) 1 500 GARY NEIL PRIZE FOR INNOVATION IN DRUG DEVELOPMENT ($2500 PER AWARD) 1 2500 GOLDSTEIN & MORROW AWARD ($1000 PER AWARD) 4 4000 HENRY W. ELLIOTT DISTINGUISHED SERVICE AWARD ($1000 PER AWARD) 1 1000 LEON I. GOLDBERG EARLY INVESTIGATOR AWARD ($1000 PER AWARD) 1 1000 OSCAR B. HUNTER CAREER AWARD IN THERAPEUTICS ($1500 PER AWARD) 1 1500 RAWLS-PALMER PROGRESS IN MEDICINE AWARD ($1000 PER AWARD) 1 1000 WILLIAM B. ABRAMS AWARD IN GERIATRIC CLINICAL PHARMACOLOGY ($1000 PER AWARD) 1 1000 PART I, LINE 2: EACH YEAR ASCPT'S AWARDS PROGRAM PROVIDES AN ARRAY OF AWARDS THAT RECOGNIZE OUTSTANDING SCIENCE AND ACHIEVEMENT IN CLINICAL PHARMACOLOGY AND TRANSLATIONAL SCIENCE. ASCPT'S AWARDS SPAN THE CONTINUUM OF CLINICAL PHARMACOLOGY, TRANSLATIONAL MEDICINE, AND THERAPEUTICS. THE ARRAY OF AWARDS IS DESIGNED TO RECOGNIZE EVERY TURNING POINT IN THE CAREER PATH FROM YOUNG INVESTIGATOR TO SEASONED SCIENTIST WITH THE FOCUS ON EXCEPTIONAL ACHIEVEMENTS IN THE DIMENSIONS THAT THE AWARDS ARE FOCUSED. EACH AWARD CANDIDATE IS NOMINATED THROUGH THE SUBMISSION OF A NOMINATION PACKET THAT INCLUDES A SUMMARIZED CV AND COMPREHENSIVE ASSESSMENT OF ALL ASPECTS OF THE CANDIDATES OUTSTANDING ATTRIBUTES. ADDITIONALLY, 1 TO 3 RECOMMENDATIONS MUST BE INCLUDED FROM INDIVIDUALS AS WELL AS THE CANDIDATES COMPLETE CV AND HIGHLIGHTS OF NOTEWORTHY SCIENTIFIC ACCOMPLISHMENTS. AFTER THE SELECTION PROCESS IS COMPLETE, THE RECIPIENTS RECEIVE THE MONETARY AWARD, A TRAVEL STIPEND TO THE ANNUAL MEETING AND RECOGNITION DURING THE ANNUAL MEETING. X X X X 0 0 0 0 0 0 0 1 0 SHARON J SWAN FASAE CAE CEO 405586 0 0 0 264 0 54574 0 10551 0 470975 0 0 0 ELISE LAFFMAN-JOHNSON COO 177698 0 0 0 264 0 13156 0 619 0 191737 0 0 0 PART I, LINE 7 THE PROCESS FOR CALCULATING THE STAFF BONUS IS DEPENDENT ON PERFORMANCE AND DISCUSSIONS WITH THE COMPENSATION COMMITTEE AND THE CEO. THE CEO'S BONUS IS CALCULATED BASED ON ACHIEVEMENT OF INCENTIVE OBJECTIVES THAT ARE APPROVED BY THE COMPENSATION COMMITTEE. BONUSES ARE USUALLY OFFERED IN THE RANGE OF 3-5% OF SALARY. FORM 990, PART VI, SECTION A, LINE 6 THE SOCIETY HAS FOUR CLASSES OF MEMBERS: FULL MEMBER, EARLY CAREER MEMBER, EMERITUS MEMBER, AND TRAINEE/STUDENT MEMBER. FULL MEMBER: FOR APPLICANTS WHO HAVE EARNED A DOCTORATE DEGREE OR EQUIVALENT IN ANY OF THE BIOMEDICAL SCIENCES. ALSO FOR APPLICANTS IN EXECUTIVE AND LEADERSHIP ROLES IN RELATED ORGANIZATIONS. APPLICANTS MUST DEMONSTRATE A SINCERE INTEREST IN, AND CONTRIBUTIONS TO, HUMAN PHARMACOLOGY AND THERAPEUTICS THROUGH PUBLICATIONS, GRANTS, PATENTS, GOVERNMENTAL REPORTS, COMPANY REPORTS, ETC. EARLY CAREER MEMBER: AN EARLY CAREER MEMBER IS A SCIENTIST IN THEIR FIRST FIVE YEARS OF PRACTICE. EMERITUS MEMBER: EMERITUS MEMBERS HAVE COMPLETED AT LEAST 20 YEARS OF MEMBERSHIP AND HAVE REACHED THE AGE OF 65. TRAINEE/STUDENT MEMBER: FOR APPLICANTS CURRENTLY ENROLLED IN A POST-DOCTORAL TRAINING PROGRAM WHO HAVE DEMONSTRATED AN INTEREST IN HUMAN PHARMACOLOGY AND THERAPEUTICS. ALSO FOR APPLICANTS WHO ARE PURSUING A POST-BACCALAUREATE DEGREE AND WHO POSSESS AN INTEREST IN HUMAN PHARMACOLOGY AND THERAPEUTICS. FORM 990, PART VI, SECTION A, LINE 7A MEMBERS SHALL HAVE SUCH VOTING PRIVILEGES AS ARE DETERMINED FROM TIME TO TIME BY THE SOCIETY'S GOVERNING BOARD AND SHALL VOTE IN SUCH MANNER AS DETERMINED BY THE GOVERNING BOARD. FORM 990, PART VI, SECTION A, LINE 7B ANY CHANGES TO THE ORGANIZATION'S BYLAWS ARE SUBJECT TO APPROVAL BY THE FULL MEMBERS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 WAS REVIEWED IN DETAIL BY THE TREASURER OF ASCPT AND MADE AVAILABLE TO ALL MEMBERS OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 12C ALL ASCPT VOLUNTEER LEADERS COMPLETE A WRITTEN CONFLICT OF INTEREST DISCLOSURE. THE CEO, LEGAL COUNSEL, AND SENIOR STAFF ARE AWARE OF CONFLICTS, AND DISCUSS ANY ACTUAL OR POTENTIAL COI ISSUES. CONFLICT OF INTEREST IS DISCUSSED AT THE BEGINNING OF EVERY BOARD OF DIRECTORS CONFERENCE CALL, WITH BOARD MEMBERS BEING ASKED TO DECLARE ANY CONFLICTS AT THE BEGINNING OF THE CALL. MONITORING AND COMPLIANCE WAS DONE WITH THE ORGANIZATIONAL STAFF MEMBERS AND LEGAL COUNSEL. FORM 990, PART VI, SECTION B, LINE 15A THE ASCPT COMPENSATION COMMITTEE REVIEWS AND APPROVES THE CEO SALARY WITH COMPARABILITY DATA AND CONTEMPORANEOUS SUBSTANTION OF THE DECISION. THE CEO REVIEWS OTHER KEY EMPLOYEES USING COMPARABILITY DATA AND CONTEMPORANEOUS SUBSTANTIATION OF THE DECISION. FORM 990, PART VI, SECTION C, LINE 19 THE GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE ON THE ASCPT WEBSITE. FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G OTHER PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 102,477. MANAGEMENT AND GENERAL EXPENSES 11,685. FUNDRAISING EXPENSES 2,488. TOTAL EXPENSES 116,650. OUTSIDE SERVICES: PROGRAM SERVICE EXPENSES 280,995. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 280,995. FORM 990, PART XII, LINE 1: THE SOCIETY PREPARES ITS FINANCIAL STATEMENTS ON THE MODIFIED CASH BASIS OF ACCOUNTING. REVENUES ARE RECOGNIZED WHEN COLLECTED RATHER THAN WHEN EARNED, AND EXPENSES ARE GENERALLY RECOGNIZED WHEN PAID RATHER THAN WHEN INCURRED. THE MODIFIED CASH BASIS OF ACCOUNTING INCLUDES THE RECORDING OF DEPRECIATION ON PROPERTY AND EQUIPMENT, AND REALIZED AND UNREALIZED GAINS AND LOSSES ON INVESTMENTS.